Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cosmetic Surgery And Procedure Market, by Procedure Type
1.4.2 Europe Cosmetic Surgery And Procedure Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
Chapter 4. Europe Cosmetic Surgery And Procedure Market by Procedure Type
4.1 Europe Non-invasive Market by Country
4.2 Europe Cosmetic Surgery And Procedure Market by Non-invasive Type
4.2.1 Europe Botox Injections Market by Country
4.2.2 Europe Laser Hair Removal Market by Country
4.2.3 Europe Soft Tissue Fillers Market by Country
4.2.4 Europe Chemical Peel Market by Country
4.2.5 Europe Microdermabrasion Market by Country
4.2.6 Europe Others Market by Country
4.3 Europe Invasive Market by Country
4.4 Europe Cosmetic Surgery And Procedure Market by Invasive Type
4.4.1 Europe Breast Augmentation Market by Country
4.4.2 Europe Liposuction Market by Country
4.4.3 Europe Nose Reshaping Market by Country
4.4.4 Europe Tummy Tuck Market by Country
4.4.5 Europe Eyelid Surgery Market by Country
4.4.6 Europe Others Market by Country
Chapter 5. Europe Cosmetic Surgery And Procedure Market by Country
5.1 Germany Cosmetic Surgery And Procedure Market
5.1.1 Germany Cosmetic Surgery And Procedure Market by Procedure Type
5.1.1.1 Germany Cosmetic Surgery And Procedure Market by Non-invasive Type
5.1.1.2 Germany Cosmetic Surgery And Procedure Market by Invasive Type
5.2 UK Cosmetic Surgery And Procedure Market
5.2.1 UK Cosmetic Surgery And Procedure Market by Procedure Type
5.2.1.1 UK Cosmetic Surgery And Procedure Market by Non-invasive Type
5.2.1.2 UK Cosmetic Surgery And Procedure Market by Invasive Type
5.3 France Cosmetic Surgery And Procedure Market
5.3.1 France Cosmetic Surgery And Procedure Market by Procedure Type
5.3.1.1 France Cosmetic Surgery And Procedure Market by Non-invasive Type
5.3.1.2 France Cosmetic Surgery And Procedure Market by Invasive Type
5.4 Russia Cosmetic Surgery And Procedure Market
5.4.1 Russia Cosmetic Surgery And Procedure Market by Procedure Type
5.4.1.1 Russia Cosmetic Surgery And Procedure Market by Non-invasive Type
5.4.1.2 Russia Cosmetic Surgery And Procedure Market by Invasive Type
5.5 Spain Cosmetic Surgery And Procedure Market
5.5.1 Spain Cosmetic Surgery And Procedure Market by Procedure Type
5.5.1.1 Spain Cosmetic Surgery And Procedure Market by Non-invasive Type
5.5.1.2 Spain Cosmetic Surgery And Procedure Market by Invasive Type
5.6 Italy Cosmetic Surgery And Procedure Market
5.6.1 Italy Cosmetic Surgery And Procedure Market by Procedure Type
5.6.1.1 Italy Cosmetic Surgery And Procedure Market by Non-invasive Type
5.6.1.2 Italy Cosmetic Surgery And Procedure Market by Invasive Type
5.7 Rest of Europe Cosmetic Surgery And Procedure Market
5.7.1 Rest of Europe Cosmetic Surgery And Procedure Market by Procedure Type
5.7.1.1 Rest of Europe Cosmetic Surgery And Procedure Market by Non-invasive Type
5.7.1.2 Rest of Europe Cosmetic Surgery And Procedure Market by Invasive Type
Chapter 6. Company Profiles
6.1 Evolus, Inc. (Alphaeon Corporation)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.2 Revance Therapeutics, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Expenses
6.3 Cynosure, LLC
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Acquisition and Mergers:
6.3.2.2 Geographical Expansions:
6.4 Alma Lasers Ltd. (Sisram Medical Ltd.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.4.5.2 Approvals and Trials:
6.5 Candela Medical Corporation (Syneron Medical Ltd.)
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Acquisition and Mergers:
6.6 Bausch Health Companies, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Lumenis Ltd.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Product Launches and Product Expansions:
6.8 Galderma S.A.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Partnerships, Collaborations, and Agreements:
6.8.2.2 Product Launches and Product Expansions:
6.8.2.3 Acquisition and Mergers:
6.9 AbbVie, Inc. (Allergan PLC)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals and Trials:
6.9.5.2 Acquisition and Mergers:
Unique Offerings 